Clinical and pathologic features influencing survival in patients undergoing pancreaticoduodenectomy for pancreatic adenocarcinoma (Q38165871)

30 August 2017

title

Clinical and pathologic features influencing survival in patients undergoing pancreaticoduodenectomy for pancreatic adenocarcinoma (English)

1 reference

30 August 2017

main subject

pancreaticoduodenectomy

0 references

1 reference

Cynthia E Weber

1

1 reference

30 August 2017

Eileen A Bock

2

1 reference

30 August 2017

Michael G Hurtuk

3

1 reference

30 August 2017

Gerard J Abood

4

1 reference

30 August 2017

Jack Pickleman

5

1 reference

30 August 2017

Margo Shoup

6

1 reference

30 August 2017

Gerard V Aranha

7

1 reference

30 August 2017

publication date

23 November 2013

1 reference

Journal of Gastrointestinal Surgery

30 August 2017

published in

1 reference

30 August 2017

volume

18

1 reference

30 August 2017

issue

2

1 reference

30 August 2017

page(s)

340-347

1 reference

Lymph node ratio and preoperative CA 19-9 levels predict overall survival and recurrence-free survival in patients with resected pancreatic adenocarcinoma

30 August 2017

cites work

1 reference

https://api.crossref.org/works/10.1007%2FS11605-013-2388-X

Prognostic factors and adjuvant chemoradiation therapy after pancreaticoduodenectomy for pancreatic adenocarcinoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11605-013-2388-X

A margin-negative R0 resection accomplished with minimal postoperative complications is the surgeon's contribution to long-term survival in pancreatic cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11605-013-2388-X

Pancreatic ductal adenocarcinoma: long-term survival does not equal cure

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11605-013-2388-X

Prognostic relevance of lymph node ratio following pancreaticoduodenectomy for pancreatic cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11605-013-2388-X

Improved survival following pancreaticoduodenectomy to treat adenocarcinoma of the pancreas: the influence of operative blood loss

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11605-013-2388-X

Prognostic factors after resection of pancreatic cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11605-013-2388-X

Classification of surgical complications: a new proposal with evaluation in a cohort of 6336 patients and results of a survey

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11605-013-2388-X

Assessment of complications after pancreatic surgery: A novel grading system applied to 633 patients undergoing pancreaticoduodenectomy.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11605-013-2388-X

Critical analysis of a large series of pancreaticogastrostomy after pancreaticoduodenectomy

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11605-013-2388-X

Zero mortality after 152 consecutive pancreaticoduodenectomies with pancreaticogastrostomy

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11605-013-2388-X

Systematic review and meta-analysis of the volume-outcome relationship in pancreatic surgery.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11605-013-2388-X

Hospital volume and late survival after cancer surgery

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11605-013-2388-X

N0/N1, PNL, or LNR? The effect of lymph node number on accurate survival prediction in pancreatic ductal adenocarcinoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11605-013-2388-X

Standard versus extended lymphadenectomy associated with pancreatoduodenectomy in the surgical treatment of adenocarcinoma of the head of the pancreas: a multicenter, prospective, randomized study. Lymphadenectomy Study Group

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11605-013-2388-X

Prognostic Significance of Pathologic Nodal Status in Patients with Resected Pancreatic Cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11605-013-2388-X

1423 pancreaticoduodenectomies for pancreatic cancer: A single-institution experience

21 January 2018

1 reference

12 December 2020

Prognosis factors in carcinoma of the head of the pancreas

1 reference

12 December 2020

The ratio of metastatic/resected lymph nodes is an independent prognostic factor in patients with node-positive pancreatic head cancer

1 reference

12 December 2020

A prospective randomized trial comparing standard pancreatoduodenectomy with pancreatoduodenectomy with extended lymphadenectomy in resectable pancreatic head adenocarcinoma

1 reference

12 December 2020

Impact of total lymph node count and lymph node ratio on staging and survival after pancreatectomy for pancreatic adenocarcinoma: a large, population-based analysis

1 reference

12 December 2020

The lymph node ratio is the strongest prognostic factor after resection of pancreatic cancer

1 reference

12 December 2020

Assessment of complications according to the Clavien-Dindo classification after distal pancreatectomy.

1 reference

12 December 2020

Lymph node ratio versus number of affected lymph nodes as predictors of survival for resected pancreatic adenocarcinoma

1 reference

12 December 2020

Role of the lymph node ratio in pancreatic ductal adenocarcinoma. Impact on patient stratification and prognosis

1 reference

12 December 2020

The metastatic/examined lymph node ratio is an important prognostic factor after pancreaticoduodenectomy for pancreatic adenocarcinoma.

1 reference

12 December 2020

10.1007/S11605-013-2388-X

Identifiers

DOI

1 reference

30 August 2017

1 reference